| 000 | 01711 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517231102.0 | ||
| 264 | 0 | _c20181231 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2018.07.048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFu, Tao-Tao | |
| 245 | 0 | 0 |
_aCiclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cOct 2018 |
||
| 300 |
_a21-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcute Lung Injury _xdrug therapy |
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBudesonide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aLipopolysaccharides |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 |
_aPregnenediones _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSuspensions |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aZhao, Yun | |
| 700 | 1 | _aYang, Fei-Fei | |
| 700 | 1 | _aWen, Han | |
| 700 | 1 | _aLiu, Chun-Yu | |
| 700 | 1 | _aLiao, Yong-Hong | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 549 _gno. 1-2 _gp. 21-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2018.07.048 _zAvailable from publisher's website |
| 999 |
_c28672190 _d28672190 |
||